CDK12 and ovarian cancer: In agreement with the results presented here, the above mentioned A2780 ovarian cancer cell line model with stable CDK12 deletion showed markedly slower proliferation, increased rates of apoptosis, and no significant reductions in HR-related proteins including ATM, BRCA1, ATR or FANCD2.